Assessing Privia Health Group’s (PRVA) Valuation After Mixed Earnings Results and Shifting Hedge Fund Activity

Simply Wall St.

2025/09/22

If you follow Privia Health Group (PRVA), you know the stock can throw curveballs at investors from time to time. The latest quarterly earnings came in with a twist: the company missed on earnings per...

网页链接

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2569736551"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2569736551\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2569736551?lang=zh_TW&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice1-main-header/1585187559063","is_english":true,"pubTime":"2025-09-22 20:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2569736551","market":"sg","top_or_hot":-1,"title":"Assessing Privia Health Group’s (PRVA) Valuation After Mixed Earnings Results and Shifting Hedge Fund Activity","media":"Simply Wall St.","content":"<div>\n<p>If you follow Privia Health Group (PRVA), you know the stock can throw curveballs at investors from time to time. The latest quarterly earnings came in with a twist: the company missed on earnings per...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-prva/privia-health-group/news/assessing-privia-health-groups-prva-valuation-after-mixed-ea\">网页链接</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Assessing Privia Health Group’s (PRVA) Valuation After Mixed Earnings Results and Shifting Hedge Fund Activity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAssessing Privia Health Group’s (PRVA) Valuation After Mixed Earnings Results and Shifting Hedge Fund Activity\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Simply Wall St.</strong><span class=\"h-time small\">2025-09-22 20:26</span>\n</p>\n</h4>\n</header>\n<article>\n<div>\n<p>If you follow Privia Health Group (PRVA), you know the stock can throw curveballs at investors from time to time. The latest quarterly earnings came in with a twist: the company missed on earnings per...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-prva/privia-health-group/news/assessing-privia-health-groups-prva-valuation-after-mixed-ea\">网页链接</a>\n\n</div>\n\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-prva/privia-health-group/news/assessing-privia-health-groups-prva-valuation-after-mixed-ea\">Simply Wall St.</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PRVA","symbol_name":"Privia Health Group, Inc.","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prva/privia-health-group/news/assessing-privia-health-groups-prva-valuation-after-mixed-ea","article_id":"2569736551","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice1-main-header/1585187559063"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prva/privia-health-group/news/assessing-privia-health-groups-prva-valuation-after-mixed-ea","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2569736551","pubTimestamp":1758543986,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"If you follow Privia Health Group (PRVA), you know the stock can throw curveballs at investors from time to time. The latest quarterly earnings came in with a twist: the company missed on earnings per share but managed to deliver revenue that topped what analysts had been expecting. In addition, there has been a shakeup among hedge fund holders. Voya Investment Management reduced its position, while other major players such as Van Berkom & Associates and UBS Asset Management added to theirs...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"PRVA":"Privia Health Group, Inc."},"translate_title":"在盈利结果好坏参半和对冲基金活动转变后评估Privia Health Group(PRVA)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRVA":1.5},"content_text":"If you follow Privia Health Group (PRVA), you know the stock can throw curveballs at investors from time to time. The latest quarterly earnings came in with a twist: the company missed on earnings per share but managed to deliver revenue that topped what analysts had been expecting. In addition, there has been a shakeup among hedge fund holders. Voya Investment Management reduced its position, while other major players such as Van Berkom & Associates and UBS Asset Management added to theirs. These conflicting signals have many investors pausing to re-evaluate their next move. Over the past year, Privia Health Group has gained about 21%, with a 14% rise so far in 2024. The momentum has picked up a bit recently, with the stock up almost 2% in the past month, even as daily moves have been mixed. Privia’s positive annual revenue growth and sharply higher net income highlight an underlying business that is expanding, yet the three-year return remains in the red. This may suggest previous volatility or shifting risk perceptions among investors. The combination of resilient operational results and divided institutional activity creates a natural tension for those weighing what comes next. Given these cross-currents, is Privia Health Group now an undervalued opportunity in disguise, or is the current price already reflecting most of its future growth? AdvertisementMost Popular Narrative: 25.8% Undervalued The most widely followed narrative currently values Privia Health Group shares as notably undervalued, projecting significant upside based on anticipated growth and business fundamentals.  Demographic tailwinds from the growing and aging U.S. population are driving sustained increases in patient volumes across Privia's network. This supports strong top-line revenue growth and predictable, recurring fee streams for the company's tech and services platform.  Curious why analysts are convinced Privia could have so much more room to run? The core argument hinges on a bold set of growth assumptions, spanning revenue, margins, and future earnings, that power this valuation. Which single financial metric holds the secret to this price target? The answer may surprise even seasoned investors who think they have the full picture. Result: Fair Value of $30.15 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, persistent labor shortages or tightening regulations could quickly alter Privia’s growth trajectory and challenge the optimistic outlook on future margins. Find out about the key risks to this Privia Health Group narrative. Another View: SWS DCF Model Says Undervalued Taking a different angle, our DCF model suggests Privia Health Group’s current price remains significantly below its estimated fair value. This method relies on projected cash flows and discounts them back to today. Which method ultimately has it right? Look into how the SWS DCF model arrives at its fair value. PRVA Discounted Cash Flow as at Sep 2025 Stay updated when valuation signals shift by adding Privia Health Group to your watchlist or portfolio. Alternatively, explore our screener to discover other companies that fit your criteria.\n Build Your Own Privia Health Group Narrative If you see things differently or want to dive deeper than the consensus, it only takes a few minutes to build your own perspective using the available data. Do it your way A good starting point is our analysis highlighting 3 key rewards investors are optimistic about regarding Privia Health Group. Looking for More Smart Investment Opportunities? Smart investors always have an edge by staying ahead of trends. Don’t limit yourself—seize your chance to uncover unique companies using powerful screeners now available on Simply Wall St.  Power up your portfolio with strong potential by tapping into undervalued stocks based on cash flows to spot quality stocks trading below their intrinsic value. Ride the AI revolution with AI penny stocks to back the most promising artificial intelligence trailblazers shaping tomorrow’s world. Unlock steady cash flow by exploring dividend stocks with yields > 3% and target companies with attractive, reliable dividend yields above 3%.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}